All National Institute for Health and Care Excellence (NICE) articles – Page 9
-
-
NewsPower flows to the centre in this year's HSJ100
The HSJ100 was launched in 2005. Each year it seeks to rank those who will exercise the greatest influence over the English NHS and health policy during the next 12 months. It is always judged by some of the most knowledgeable and experienced figures in healthcare leadership.
-
NewsNew pharma deal raises cap on drugs' spending
The government has negotiated a new deal with the pharmaceutical industry which raises the NHS’ cap on spending on branded medicines.
-
CommentChange won’t happen by accident
Axel Heitmueller suggests the government should develop a change model to enable transformation of health services, especially in light of the move towards integrated care
-
NewsQuarter of CCGs fall below psychosis spend benchmark
Nearly a quarter of clinical commissioning groups are spending less than the estimated sum needed to provide proper care to seriously ill mental health patients, according to a new analysis by HSJ.
-
NewsLabour plans safe staffing amendments to healthcare safety bill
Labour have threatened to table amendments to the government’s Healthcare Safety Bill if ministers fail to take action on three areas of patient safety in the NHS 10 year plan.
-
NewsNHS wins landmark legal battle against drug companies
The NHS has today won a landmark legal battle against two international pharmaceutical giants which could save the health service hundreds of millions of pounds a year.
-
Expert BriefingThe Integrator: How quickly is general practice reforming?
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ primary care and community services correspondent Rebecca Thomas.
-
Expert BriefingThe Integrator: "Loaded gun" medicine plans may richochet back onto government
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan
-
NewsCharity accuses royal college of 'dangerous' advice on 'normal births'
A charity has criticised a royal college for what it said was “immensely dangerous” support of a trust’s “normal birth” campaign.
-
Expert BriefingThe Integrator: Expensive drug dilemmas need a sophisticated approach
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan.
-
NewsThousands of NHS patients put at risk of preventable strokes
Thousands of patients are being put at risk of preventable strokes leading to death and life long disability because of poor management by the NHS, HSJ has been told.
-
NewsNHS England tells staff groups to act on flu vaccine
NHS England is calling on the royal colleges to provide an action plan to encourage uptake of the flu vaccine among staff, after a clinical study made a direct link between vaccination and mortality rates.
-
CommentResponding to the danger signs of CAMHS in trouble
Mental healthcare and treatment, for children and young people in particular, has historically been the ‘poor relation’ of the NHS, writes Dr Nick Wagget
-
CommentCowper’s Cut: Mandatory guidance
Empowering patients and offering greater choice are good things – they are just not free good things, writes Andy Cowper
-
CommentFive legal changes the health service needs
Tom Kibasi and Toby Lambert argue the health service should seize on the government’s offer of legislative reform, and set out five changes it needs to take integration forward.
-
NewsLord Darzi appointed chair of new innovation panel
Former health minister Lord Darzi has been appointed chair of a new innovation panel which will choose which “transformative” medical products should be fast tracked into the NHS.
-
HSJ InteractiveWhat benefits can biosimilars bring to the NHS?
Alison Moore reports on an HSJ roundtable which explored how the biosimilars market can be expanded, what the potential benefits and challenges are, and what needs to be done to increase uptake
-
NewsMinister: 'We got it wrong on Hep C drug'
A health minister said the NHS needs to be better prepared for the budget impact of new medicines such as the oral drug for Hepatitis C, and admitted “we didn’t get it right”.
-
NewsAHSNs beefed up amid overhaul of £750m 'innovation' budgets
Ministers and NHS leaders are planning to beef up the role of academic health science networks and overhaul how £750m of “innovation” funding is deployed.